Author:
Scheinberg Morton A.,Kay Jonathan
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Hyrich, K. L. et al. Outcomes after switching from one anti-tumor necrosis factor α agent to a second anti-tumor necrosis factor α agent in patients with rheumatoid arthritis: results from a large UK national cohort study. Arthritis Rheum. 56, 13–20 (2007).
2. Patent status information—register entry for European Patent 0343684. Intellectual Property Office
[online]
(2009).
3. Patent status information—register entry for European Patent 0409607 Intellectual Property Office
[online]
(2009).
4. US$54 billion worth of biosimilar patents expiring before 2020. Generics and Biosimilars Initiative Online
[online]
, (2011).
5. Medtrack
[online]
, (2012).
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献